Search alternatives:
point decrease » point increase (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 point » _ point (Expand Search)
Showing 1,061 - 1,080 results of 100,255 for search '(( 5 point decrease ) OR ( 5 ((wt decrease) OR (((teer decrease) OR (a decrease)))) ))', query time: 1.49s Refine Results
  1. 1061
    Transgenic <i>Eμ-V<sub>H</sub>-OBF1</i> mice are immunodeficient due to decreased numbers of follicular B cells.

    Transgenic <i>Eμ-V<sub>H</sub>-OBF1</i> mice are immunodeficient due to decreased numbers of follicular B cells. by Alain Bordon (57422)

    Published 2008
    Save to List
    Saved in:
  2. 1062
    Effects of conivaptan on brain water content (BWC), blood-brain-barrier (BBB) disruption, plasma and urine sodium and osmolality.

    Effects of conivaptan on brain water content (BWC), blood-brain-barrier (BBB) disruption, plasma and urine sodium and osmolality. by Emil Zeynalov (596088)

    Published 2015
    “…Following MCAO, Evans Blue (EB) extravasation index (I/C) was increased in vehicle treated mice, and reduced in conivaptan treated mice, naïve, n = 5, vehicle, n = 8, Conivaptan 0.2 mg, n = 8. (C, D) Conivaptan treatment of 0.2 mg resulted in an elevation of plasma sodium and osmolality, and decreased urine sodium and osmolality due to aquaresis. …”
    Save to List
    Saved in:
  3. 1063
    Effects of tolvaptan on brain water content (BWC), plasma and urine sodium and osmolality.

    Effects of tolvaptan on brain water content (BWC), plasma and urine sodium and osmolality. by Emil Zeynalov (596088)

    Published 2015
    Save to List
    Saved in:
  4. 1064
    Sost and Sclerostin Expression are Decreased and Wnt Signaling is Increased in DMP1-caPTHR1 Transgenic Mice.

    Sost and Sclerostin Expression are Decreased and Wnt Signaling is Increased in DMP1-caPTHR1 Transgenic Mice. by Charles A. O'Brien (271071)

    Published 2008
    Save to List
    Saved in:
  5. 1065
    The authorship rating was a 6-point rating scale of the degree of authorship, ranging from 1 “I could not manipulate the window at all” to 6 “I completely manipulated the window”.

    The authorship rating was a 6-point rating scale of the degree of authorship, ranging from 1 “I could not manipulate the window at all” to 6 “I completely manipulated the window”.... by Junhui Kim (18575083)

    Published 2024
    Save to List
    Saved in:
  6. 1066
    <i>neurod1</i><sup><i>ΔUCE</i></sup> homozygous mutants display an increase of the goblet cells concomitant with a decrease of EECs.

    <i>neurod1</i><sup><i>ΔUCE</i></sup> homozygous mutants display an increase of the goblet cells concomitant with a decrease of EECs. by Anne Sophie Reuter (12239993)

    Published 2022
    Save to List
    Saved in:
  7. 1067
    cDNA sequencing reveals missense point mutations in the UBA3 coding region of MLN4924-resistant K562 cells which decrease the sensitivity of NAE to MLN4924 in vitro.

    cDNA sequencing reveals missense point mutations in the UBA3 coding region of MLN4924-resistant K562 cells which decrease the sensitivity of NAE to MLN4924 in vitro. by G. Wei Xu (545673)

    Published 2014
    Save to List
    Saved in:
  8. 1068
    Dose- and time-dependent effect of IFN-γ and TNF-α on benzamil-sensitive <i>I</i><sub>sc</sub> and TEER in HBECs.

    Dose- and time-dependent effect of IFN-γ and TNF-α on benzamil-sensitive <i>I</i><sub>sc</sub> and TEER in HBECs. by Anusree Sasidharan (19226521)

    Published 2024
    Save to List
    Saved in:
  9. 1069
    Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis - Fig 5

    Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis - Fig 5 by Naoki Kawagishi (6111821)

    Published 2018
    Save to List
    Saved in:
  10. 1070
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  11. 1071
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  12. 1072
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  13. 1073
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  14. 1074
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  15. 1075
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  16. 1076
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  17. 1077
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  18. 1078
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  19. 1079
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  20. 1080
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:

Search Tools: